For: | Tong WB, Zhang CY, Feng BF, Tao QM. Establishment of a nonradioactive assay for2’-5’ oligoadenylate synthetase and its application in chronic hepatitis C patients receiving interferon-α. World J Gastroenterol 1998; 4(1): 70-73 [PMID: 11819237 DOI: 10.3748/wjg.v4.i1.70] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v4/i1/70.htm |
Number | Citing Articles |
1 |
Lin Zhuang, Jing You, Bao-Zhang Tang, Su-Ying Ding, Kui-Hua Yan, Dan Peng, Yan-Mei Zhang, Lu Zhang. Preliminary results of Thymosin-a1 <i>vs</i> interferon-α treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World Journal of Gastroenterology 2001; 7(3): 407-410 doi: 10.3748/wjg.v7.i3.407
|
2 |
Soo Ryang Kim, Susumu Imoto, Shuichi Fuki, Ke Ih Kim, Miyuki Taniguchi, Motoko Nagano, Hak Hotta, Ikuo Shouji, Yoshihiro Kanbara, Yoko Maekawa, Masatoshi Kudo, Yoshitake Hayashi. Pegylated interferon α-2b/ribavirin combination therapy for elderly patients with chronic hepatitis C with high viral load of HCV genotype 1b. Kanzo 2008; 49(4): 145 doi: 10.2957/kanzo.49.145
|
3 |
Jing You, Hong-Ying Cheng, Shou-Ming Yan, Yan-Wei Qiao, Jun-Hua Huang, Bao-Zhang Tang, Guo-Bing Wu, Jun-Yan Qu, Rong-Xue Wu, Lin Zhuang, Yong-Liang Ma. A Randomized, Controlled, Clinical Study of Thymosin Alpha-1 Versus Interferon-Alpha in Chinese Patients with Chronic Hepatitis B Lacking Hepatitis B Envelope Antigen. Journal of the Chinese Medical Association 2005; 68(2): 65 doi: 10.1016/S1726-4901(09)70137-6
|
4 |
Xi Peng, Jin-Bin Feng, Hong Yan, Yun Zhao, Shi-Liang Wang. Distribution of nitric oxide synthase in stomach myenteric plexus of rats. World Journal of Gastroenterology 2001; 7(6): 852-854 doi: 10.3748/wjg.v7.i6.852
|
5 |
Chao-Pin Li, Ke-Xia Wang, Jian Wang, Bo-Rong Pan. mIL-2R, T cell subsets and hepatitis C. World Journal of Gastroenterology 2002; 8(2): 298-300 doi: 10.3748/wjg.v8.i2.298
|
6 |
Jing You, Lin Zhuang, Bao-Zhang Tang, Wei-Bo Yang, Su-Ying Ding, Wu Li, Rong-Xue Wu, Hong-Li Zhang, Yan-Mei Zhang, Shao-Ming Yan, Lu Zhang. Randomized controlled clinical trial on the treatment of Thymosin-a1 <i>vs</i> interferon-α in patients with hepatitis B. World Journal of Gastroenterology 2001; 7(3): 411-414 doi: 10.3748/wjg.v7.i3.411
|
7 |
Jing You, Lin Zhuang, Hong-Ying Cheng, Shou-Ming Yan, Lan Yu, Jun-Hua Huang, Bao-Zhang Tang, Meng-Ling Huang, Yong-Liang Ma, Virasakdi Chongsuvivatwong, Hutcha Sriplung, Alan Geater, Yan-Wei Qiao, Rong-Xue Wu. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: A randomized controlled study. World Journal of Gastroenterology 2006; 12(41): 6715-6721 doi: 10.3748/wjg.v12.i41.6715
|
8 |
K.-I. Kim, S.-R. Kim, N. Sasase, M. Taniguchi, S. Harada, K. Kinoshita, S.-H. Kim, Y. Akimoto, M. Shikata, N. Kimura, S. Izawa, A. Ohtani, K. Nakao, M. Motojima, M. Kinoshita, M. Hirai, M. Ohzu, T. Hirooka, S. Nabeshima, F. Ishii, K. Tanaka, H. Hotta. 2'-,5'-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C. Journal of Clinical Pharmacy and Therapeutics 2006; 31(5): 441 doi: 10.1111/j.1365-2710.2006.00761.x
|